Bodyweight Gain Associated with Atypical Antipsychotics
- 1 January 2001
- journal article
- review article
- Published by Springer Science and Business Media LLC in CNS Drugs
- Vol. 15 (7), 537-551
- https://doi.org/10.2165/00023210-200115070-00004
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- OlanzapinePharmacoEconomics, 1999
- QuetiapineCNS Drugs, 1998
- Quetiapine (‘Seroquel’); an effective and well-tolerated atypical antipsychoticInternational Journal of Psychiatry in Clinical Practice, 1997
- Bodyweight Change as an Adverse Effect of Drug TreatmentDrug Safety, 1996
- Radioreceptor Binding Profile of the Atypical Antipsychotic OlanzapineNeuropsychopharmacology, 1996
- Diet and gender moderate clozapine‐related weight gainHuman Psychopharmacology: Clinical and Experimental, 1995
- Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in MenDiabetes Care, 1994
- Weight Gain Associated With Psychotropic DrugsSouthern Medical Journal, 1989
- DIABETES AND SCHIZOPHRENIA—A PRELIMINARY STUDYJournal of Clinical Pharmacy & Therapeutics, 1986
- Drug-induced Weight GainDrugs, 1980